MedTrace Logo

Non-invasive Monitoring of Miscarriage

NCT06581692 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-11-12

No results posted yet for this study

Summary

cfDNA is extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test. This study aims to determine the level of cell-free DNA (cfDNA) in early pregnancy and compare the results with those of product of conception (POC) testing, in concordance with standard karyotyping.

Conditions

  • Miscarriage in First Trimester

Interventions

OTHER

This is a routine procedure, no intervention will be provided.

This is a routine procedure, no intervention will be provided.

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • PUI WAH JACQUELINE CHUNG · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2039-08-31
Completion
2039-08-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06581692 on ClinicalTrials.gov